Matrix metalloproteinases in neuroinflammation (Q34803809)

4 August 2017

1 reference

title

Matrix metalloproteinases in neuroinflammation (English)

1 reference

4 August 2017

0 references

Gary A Rosenberg

1

1 reference

4 August 2017

publication date

1 September 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

39

1 reference

4 August 2017

issue

3

1 reference

4 August 2017

page(s)

279-291

1 reference

Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94.

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Characterization of a putative p53 binding site in the promoter of the mouse tissue inhibitor of metalloproteinases-3 (TIMP-3) gene: TIMP-3 is not a p53 target gene.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Tissue inhibitors of metalloproteinases: evolution, structure and function

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Protease production by cultured microglia: substrate gel analysis and immobilized matrix degradation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Very delayed infarction after mild focal cerebral ischemia: a role for apoptosis?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Processing of tumour necrosis factor-α precursor by metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Programmed cell death in cerebral ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases increase very early during experimental focal cerebral ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinase expression during experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Quantitative zymography: detection of picogram quantities of gelatinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Microglial cells are a component of the perivascular glia limitans

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Intact aggrecan and fragments generated by both aggrecanse and metalloproteinase-like activities are present in the developing and adult rat spinal cord and their relative abundance is altered by injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Inhibition of the putative tumor suppressor gene TIMP-3 by tumor-derived p53 mutants and wild type p53.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Extracellular matrix degradation by metalloproteinases and central nervous system diseases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Regulation of tumour necrosis factor-alpha processing by a metalloproteinase inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix Metalloproteinase Expression After Human Cardioembolic Stroke

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases in cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases: biologic activity and clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

The inflammatory response in the CNS.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Extracellular matrix-degrading proteinases in the nervous system

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases in brain injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases in multiple sclerosis: is it time for a treatment trial?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Metalloproteinase inhibition blocks edema in intracerebral hemorrhage in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Proteolytic cascade enzymes increase in focal cerebral ischemia in rat

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Immunohistochemistry of matrix metalloproteinases in reperfusion injury to rat brain: activation of MMP-9 linked to stromelysin-1 and microglia in cell cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

White matter damage is associated with matrix metalloproteinases in vascular dementia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Coordinate expression of matrix metalloproteinase family members in the uterus of normal, matrilysin-deficient, and stromelysin-1-deficient mice

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Changes of serum sICAM-1 and MMP-9 induced by rIFN -1b treatment in relapsing-remitting MS

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Cytotoxicity by matrix metalloprotease-1 in organotypic spinal cord and dissociated neuronal cultures

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi-competitor cDNA standard.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Metalloproteinases in biology and pathology of the nervous system.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.10108

7 January 2021

Identifiers

DOI

10.1002/GLIA.10108

1 reference

4 August 2017

1 reference